Page last updated: 2024-12-07

wr 151327

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

WR 151327: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID100632
CHEMBL ID159464
SCHEMBL ID134214
MeSH IDM0139242

Synonyms (16)

Synonym
nsc335662
nsc-335662
82147-31-7
wr-151327
3-[3-(methylamino)propylamino]propylsulfanylphosphonic acid
1-propanethiol, 3-((3-(methylamino)propyl)amino), dihydrogen phosphate (ester)
wr 151327
methylaminopropylaminopropylthiophosphorate
nsc 335662
CHEMBL159464
3-(3-methylaminopropylamino)propylsulfanylphosphonic acid
SCHEMBL134214
DTXSID80231592
1-propanethiol, 3-[[3-(methylamino)propyl]amino]-, dihydrogen phosphate (ester)
MN3P5HXJ8B
1-propanethiol, 3-[[3-(methylamino)propyl]amino]-, 1-(dihydrogen phosphate)

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" There is also evidence that aminothiols are toxic to the germinal cell layer of the seminiferous tubules when given to sham-irradiated mice."( Comparative intestinal and testes toxicity of four aminothiols in irradiated and nonirradiated mice.
Eckstein, JM; Egan, JE; Heman-Ackah, LM; Jackson, WE; Kendrick, JM; Steel-Goodwin, L,
)
0.13

Compound-Compound Interactions

ExcerptReferenceRelevance
" The calcium channel blocker nimodipine (NIMO) was administered alone (1 or 10 mg kg-1) or in combination with 200 mg kg-1 of the phosphorothioate radioprotector WR-151327 (WR) (S-3-(3-methylaminopropylamino)propylphosphorothioic acid)."( Radioprotective and locomotor responses of mice treated with nimodipine alone and in combination with WR-151327.
Benson, KA; Castro, CA; Hogan, JB; Landauer, MR; Weiss, JF,
)
0.13

Dosage Studied

ExcerptRelevanceReference
" Pathological examination at 8, 30 or 90 days post administration of 100, 450, or 900 mg per kg of the drug demonstrated that the major target organ for orally dosed mice was the testes."( Pathological evaluation of WR-151327 administered orally in irradiated and non-irradiated male mice.
Eckstein, JM; Egan, JE; Kendrick, JM; Steel-Goodwin, L,
)
0.13
" Group means and standard deviations were calculated and dose-response curves were drawn for every endpoint."( Radioprotection by WR-151327 against the late normal tissue damage in mouse hind legs from gamma ray radiation.
Ando, K; Furukawa, S; Grdina, DJ; Koike, S; Matsushita, S, 1994
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (25.00)18.7374
1990's7 (58.33)18.2507
2000's2 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.73

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.73 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.50 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.73)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]